GENETIC RECOMBINATION: THE NATURE OF A CROSSED STRAND-EXCHANGE BETWEEN TWO HOMOLOGOUS DNA MOLECULESSIGAL N; ALBERTS B.1972; J. MOLEC. BIOL.; G.B.; DA. 1972; VOL. 71; NO 3; PP. 789-793; H.T. 2; BIBL. 18REF.Serial Issue

A DNA-UNWINDING PROTEIN ISOLATED FROM ESCHERICHIA COLI: ITS INTERACTION WITH DNA AND WITH DNA POLYMERASESSIGAL N; DELIUS H; KORNBERG T et al.1972; PROC. NATION. ACAD. SCI.; U.S.A.; DA. 1972; VOL. 69; NO 12; PP. 3537-3541; BIBL. 24REF.Serial Issue

PURIFICATION AND PROPERTIES OF A DEBRANCHING ENZYME FROM ESCHERICHIA COLI.JEANNINGROS R; CREUZET SIGAL N; FRIXON C et al.1976; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1976; VOL. 438; NO 1; PP. 186-199; BIBL. 29 REF.Article

Cyclosporin A, FK-506, and rapamycin : pharmacologic probes of lymphocyte signal transductionSIGAL, N. H; DUMONT, F. J.Annual review of immunology. 1992, Vol 10, pp 519-560, issn 0732-0582Article

Limiting dilution analysis of Epstein-Barr virus-induced immunoglobulin productionSTEIN, L. D; SIGAL, N. H.Cellular immunology (Print). 1983, Vol 79, Num 2, pp 309-319, issn 0008-8749Article

Avtodizel' open joint-stock company specifications for motor oilsARTEM'EV, V. A; BOIKOV, D. V; SIGAL, N. I et al.Chemistry and technology of fuels and oils. 2001, Vol 37, Num 2, pp 110-113, issn 0009-3092Article

Observations on the mechanism of action of FK-506 : a pharmacologic probe of lymphocyte signal transduction. CommentarySIGAL, N. H; SIEKIERKA, J. J; DUMONT, F. J et al.Biochemical pharmacology. 1990, Vol 40, Num 10, pp 2201-2208, issn 0006-2952, 8 p.Article

Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosisSTARUCH, M.-J; SIGAL, N. H; DUMONT, F. J et al.International journal of immunopharmacology. 1991, Vol 13, Num 6, pp 677-685, issn 0192-0561Article

In vitro regulation of IgA subclass production. III: Selective transformation of IGA1 producing cells by Epstein-Barr virusCONLEY, M. E; CHAN, M. A; SIGAL, N. H et al.The Journal of immunology (1950). 1987, Vol 138, Num 5, pp 1403-1407, issn 0022-1767Article

Isolation of a human cDNA encoding a 25 kDA FK-506 and rapamycin binding proteinWIEDERRECHT, G; MARTIN, M. M; SIGAL, N. H et al.Biochemical and biophysical research communications (Print). 1992, Vol 185, Num 1, pp 298-303, issn 0006-291XArticle

The enzymatic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175POE, M; WU, J. K; BLAKE, J. T et al.Archives of biochemistry and biophysics (Print). 1991, Vol 284, Num 1, pp 215-218, issn 0003-9861, 4 p.Article

FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytesSHIRLEY LIN, C; BOLTZ, R. C; SIEKIERKA, J. J et al.Cellular immunology (Print). 1991, Vol 133, Num 2, pp 269-284, issn 0008-8749Article

Heterogeneity of EBV-transformable human B lymphocyte populationsCHAN, M. A; STEIN, L. D; DOSCH, H.-M et al.The Journal of immunology (1950). 1986, Vol 136, Num 1, pp 106-112, issn 0022-1767Article

FKBP, the binding protein for the immunosuppressive drug, FK-506, is not an inhibitor of protein kinase C activityCRYAN, J; HUNG, S. H. Y; WIEDERRECHT, G et al.Biochemical and biophysical research communications (Print). 1991, Vol 180, Num 2, pp 846-852, issn 0006-291XArticle

Human cytotoxic lymphocyte granzyme B : its purification from granules and the characterization of substrate and inhibitor specificityPOE, M; BLAKE, J. T; BOULTON, D. A et al.The Journal of biological chemistry (Print). 1991, Vol 266, Num 1, pp 98-103, issn 0021-9258, 6 p.Article

A human monoclonal antibody that protects mice against Pseudomonas-induced pneumoniaZWEERINK, H. J; DETOLLA, L. J; GAMMON, M. C et al.The Journal of infectious diseases. 1990, Vol 162, Num 1, pp 254-257, issn 0022-1899Article

The human and murine influenza-specific B cell repertoires share a common idiotopeSIGAL, N. H; CHAN, M; REALE, M. A et al.The Journal of immunology (1950). 1987, Vol 139, Num 6, pp 1985-1990, issn 0022-1767Article

Regulation of class II MHC molecules on human endothelial cells: effects of IFN and dexamethasoneMANYAK, C. L; TSE, H; FISCHER, P et al.The Journal of immunology (1950). 1988, Vol 140, Num 11, pp 3817-3821, issn 0022-1767Article

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinSIEKIERKA, J. J; HUNG, S. H. Y; POE, M et al.Nature (London). 1989, Vol 342, Num 6244, pp 755-757, issn 0028-0836Article

Ecto-5'-nucleotidase. I: Expression in human normal and neoplastic lymphoid cell lines representing sequential stages of B-cell differentiationSENGUPTA, S; HIBI, T; MACKAY, A et al.Journal of the National Cancer Institute. 1984, Vol 73, Num 5, pp 1075-1080, issn 0027-8874Article

Analogs of cyclosporin a modified at the d-ALA⁸ positionPATCHETT, A. A; TAUB, D; HENSENS, O. D et al.Journal of antibiotics (Tokyo. 1968). 1992, Vol 45, Num 1, pp 94-102, issn 0021-8820Article

Suppression of B cell activation by cyclosporin A, FK506 and rapamycinWICKER, L. S; BOLTZ, R. C; MATT, V et al.European journal of immunology. 1990, Vol 20, Num 10, pp 2277-2283, issn 0014-2980, 7 p.Article

Large, activated B cells are the primary B-cell target of 8-bromoguanosine and 8-mercaptoguanosineWICKER, L. S; BOLTZ, R. C. JR; NICHOLS, E. A et al.Cellular immunology (Print). 1987, Vol 106, Num 2, pp 318-329, issn 0008-8749Article

Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complexWIEDERRECHT, G; HUNG, S; KAREN CHAN, H et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 30, pp 21753-21760, issn 0021-9258Article

Human cytotoxic lymphocyte tryptase: its purification from granules and the characterization of inhibitor and substrate specificityPOE, M; BENNETT, C. D; BIDDISON, W. E et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 26, pp 13215-13222, issn 0021-9258Article